---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013620"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:42:46.299046+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix appoints Doron Besser as CEO; Brian Murphy retires but stays on board

## Summary
- Brian Murphy retired as CEO of NanoVibronix effective June 4, 2025, and will remain as a director.
- Doron Besser, previously CEO of subsidiary ENvue Medical Holdings, appointed as CEO effective same date.
- NanoVibronix completed acquisition of ENvue on February 14, 2025, creating a combined growth platform.
- Besser has a medical device background; previously helped lead superDimension, acquired by Covidien for ~$300M.
- Board Chairman Christopher Fashek thanked Murphy and expressed confidence in Besser's leadership.

## SEC filing metadata
- accession: 0001641172-25-013620
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013620
- JSON: https://secwatch.observer/filing/0001641172-25-013620.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013620.txt

## Key facts
- Executive change
  Doron Besser was appointed as Chief Executive Officer at ENvue Medical, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: the Board of Directors (the “ Board ”) of NanoVibronix, Inc. (the “ Company ”) appointed Doron Besser, M.D., a director of the Board and Chief Executive Officer and President of the Company’s wholly-owned subsidiary, ENvue Medical Holdings LLC (“ ENvue ”), as the Company’s Chief Executive Officer (“ CEO ”), effective as of the same date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm
- Executive change
  Brian Murphy resigned as Chief Executive Officer at ENvue Medical, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Brian Murphy resigned from the Company as its CEO due to Mr. Murphy’s retirement, effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.